Biotech Values

[DewDiligence]

MON uses RNAi in its corn-rootworm trait, which is in phase-3 development (#msg-70545277). The new license with MRNA presumably means that MON seeks to expand the use of RNAi, although the value of MRNA’s contribution to this effort is apt to be small insofar as the financial terms of the license were not disclosed.